Victor Dzau

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Frenkel Dan; Pachori Alok S; Zhang Lunan; Dembinsky-Vaknin Adi; Farfara Dorit; Petrovic-Stojkovic Sanja; Dzau Victor J; Weiner Howard L
Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.
Gnecchi Massimiliano; He Huamei; Melo Luis G; Noiseaux Nicolas; Morello Fulvio; de Boer Rudolf A; Zhang Lunan; Pratt Richard E; Dzau Victor J; Ingwall Joanne S
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.
Zhang Zhongyan; Deb Arjun; Zhang Zhiping; Pachori Alok; He Wei; Guo Jian; Pratt Richard; Dzau Victor J
Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Victor Dzau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Frenkel Dan; Pachori Alok S; Zhang Lunan; Dembinsky-Vaknin Adi; Farfara Dorit; Petrovic-Stojkovic Sanja; Dzau Victor J; Weiner Howard L
Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.
International immunology 2009;21(7):817-29.
2009: Gnecchi Massimiliano; He Huamei; Melo Luis G; Noiseaux Nicolas; Morello Fulvio; de Boer Rudolf A; Zhang Lunan; Pratt Richard E; Dzau Victor J; Ingwall Joanne S
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.
Stem cells (Dayton, Ohio) 2009;27(4):971-9.
2009: Zhang Zhongyan; Deb Arjun; Zhang Zhiping; Pachori Alok; He Wei; Guo Jian; Pratt Richard; Dzau Victor J
Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a.
Journal of molecular and cellular cardiology 2009;46(3):370-7.
2008: Gnecchi Massimiliano; Zhang Zhiping; Ni Aiguo; Dzau Victor J
Paracrine mechanisms in adult stem cell signaling and therapy.
Circulation research 2008;103(11):1204-19.
2008: Michener J Lloyd; Yaggy Susan; Lyn Michelle; Warburton Samuel; Champagne Mary; Black MaryAnn; Cuffe Michael; Califf Robert; Gilliss Catherine; Williams R Sanders; Dzau Victor J
Improving the health of the community: Duke's experience with community engagement.
Academic medicine : journal of the Association of American Medical Colleges 2008;83(4):408-13.
2008: Williams R Sanders; Casey Patrick J; Kamei Robert K; Buckley Edward G; Soo Khee Chee; Merson Michael H; Krishnan Ranga K; Dzau Victor J
A global partnership in medical education between Duke University and the National University of Singapore.
Academic medicine : journal of the Association of American Medical Colleges 2008;83(2):122-7.
2008: Deb Arjun; Davis Bryce H; Guo Jian; Ni Aiguo; Huang Jing; Zhang Zhiping; Mu Hui; Dzau Victor J
SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a.
Stem cells (Dayton, Ohio) 2008;26(1):35-44.
2007: Pachori Alok S; Smith Anthony; McDonald Patricia; Zhang Lunan; Dzau Victor J; Melo Luis G
Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway.
Journal of molecular and cellular cardiology 2007;43(5):580-92.
2007: Ip James E; Wu Yaojiong; Huang Jing; Zhang Lunan; Pratt Richard E; Dzau Victor J
Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment.
Molecular biology of the cell 2007;18(8):2873-82.
2007: Liu Xiaoli; Simpson Jeremy A; Brunt Keith R; Ward Christopher A; Hall Sean R R; Kinobe Robert T; Barrette Valerie; Tse M Yat; Pang Stephen C; Pachori Alok S; Dzau Victor J; Ogunyankin Kofo O; Melo Luis G
Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction.
American journal of physiology. Heart and circulatory physiology 2007;293(1):H48-59.
2007: Mirotsou Maria; Zhang Zhongyan; Deb Arjun; Zhang Lunan; Gnecchi Massimiliano; Noiseux Nicolas; Mu Hui; Pachori Alok; Dzau Victor
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(5):1643-8.
2006: Dzau Victor J; Antman Elliott M; Black Henry R; Hayes David L; Manson JoAnn E; Plutzky Jorge; Popma Jeffrey J; Stevenson William
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.
Circulation 2006;114(25):2871-91.
2006: Dzau Victor J; Antman Elliott M; Black Henry R; Hayes David L; Manson JoAnn E; Plutzky Jorge; Popma Jeffrey J; Stevenson William
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).
Circulation 2006;114(25):2850-70.
2006: Matsushita Kenichi; Wu Yaojiong; Okamoto Yoshihisa; Pratt Richard E; Dzau Victor J
Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.
Hypertension 2006;48(6):1095-102.
2006: Noiseux Nicolas; Gnecchi Massimiliano; Lopez-Ilasaca Marco; Zhang Lunan; Solomon Scott D; Deb Arjun; Dzau Victor J; Pratt Richard E
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(6):840-50.
2006: Mirotsou Maria; Dzau Victor J; Pratt Richard E; Weinberg Ellen O
Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy.
Physiological genomics 2006;27(1):86-94.
2006: Wu Yaojiong; Ip James E; Huang Jing; Zhang Lunan; Matsushita Kenichi; Liew Choong-Chin; Pratt Richard E; Dzau Victor J
Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium.
Circulation research 2006;99(3):315-22.
2006: Gnecchi Massimiliano; He Huamei; Noiseux Nicolas; Liang Olin D; Zhang Lunan; Morello Fulvio; Mu Hui; Melo Luis G; Pratt Richard E; Ingwall Joanne S; Dzau Victor J
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(6):661-9.
2006: Pachori Alok S; Melo Luis G; Zhang Lunan; Solomon Scott D; Dzau Victor J
Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery.
Journal of the American College of Cardiology 2006;47(3):635-43.
2006: Liu Xiaoli; Pachori Alok S; Ward Christopher A; Davis J Paul; Gnecchi Massimiliano; Kong Deling; Zhang Lunan; Murduck Jared; Yet Shaw-Fang; Perrella Mark A; Pratt Richard E; Dzau Victor J; Melo Luis G
Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(2):207-16.
2006: Pachori A S; Melo L G; Dzau V J
Gene therapy: role in myocardial protection.
Handbook of experimental pharmacology 2006;(176 Pt 2):335-50.
2005: Goldschmidt-Clermont Pascal J; Creager Mark A; Losordo Douglas W; Lam Gregory K W; Wassef Momtaz; Dzau Victor J
Atherosclerosis 2005: recent discoveries and novel hypotheses.
Circulation 2005;112(21):3348-53.
2005: Sales Virna L; Sukhova Galina K; Lopez-Ilasaca Marco A; Libby Peter; Dzau Victor J; Pratt Richard E
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.
Circulation 2005;112(21):3328-36.
2005: Dzau Victor J; Gnecchi Massimiliano; Pachori Alok S
Enhancing stem cell therapy through genetic modification.
Journal of the American College of Cardiology 2005;46(7):1351-3.
2005: Dzau Victor J; Lopez-Ilasaca Marco
Searching for transcriptional regulators of Ang II-induced vascular pathology.
The Journal of clinical investigation 2005;115(9):2319-22.
2005: Cunha-Neto Edecio; Dzau Victor J; Allen Paul D; Stamatiou Dimitri; Benvenutti Luiz; Higuchi M Lourdes; Koyama Natalia S; Silva Joao S; Kalil Jorge; Liew Choong-Chin
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.
The American journal of pathology 2005;167(2):305-13.
2005: Morello Fulvio; de Boer Rudolf A; Steffensen Knut R; Gnecchi Massimiliano; Chisholm Jeffrey W; Boomsma Frans; Anderson Leonard M; Lawn Richard M; Gustafsson Jan-Ake; Lopez-Ilasaca Marco; Pratt Richard E; Dzau Victor J
Liver X receptors alpha and beta regulate renin expression in vivo.
The Journal of clinical investigation 2005;115(7):1913-22.
2005: Dzau Victor J; Gnecchi Massimiliano; Pachori Alok S; Morello Fulvio; Melo Luis G
Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.
Hypertension 2005;46(1):7-18.
2005: Melo Luis G; Pachori Alok S; Gnecchi Massimiliano; Dzau Victor J
Genetic therapies for cardiovascular diseases.
Trends in molecular medicine 2005;11(5):240-50.
2005: Dzau Victor
The cardiovascular continuum and renin-angiotensin-aldosterone system blockade.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2005;23(1):S9-17.
2005: Gnecchi Massimiliano; He Huamei; Liang Olin D; Melo Luis G; Morello Fulvio; Mu Hui; Noiseux Nicolas; Zhang Lunan; Pratt Richard E; Ingwall Joanne S; Dzau Victor J
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.
Nature medicine 2005;11(4):367-8.
2005: Guo Shaodong; Lopez-Ilasaca Marco; Dzau Victor J
Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation.
The Journal of biological chemistry 2005;280(13):12536-41.
2005: Sussman Andrew J; Otten Jeffrey R; Goldszer Robert C; Hanson Margaret; Trull David J; Paulus Kenneth; Brown Monte; Dzau Victor; Brennan Troyen A
Integration of an academic medical center and a community hospital: the Brigham and Women's/Faulkner hospital experience.
Academic medicine : journal of the Association of American Medical Colleges 2005;80(3):253-60.
2005: Lopez-Ilasaca Marco A; Bernabe-Ortiz Julio C; Na Soon-Young; Dzau Victor J; Xavier Ramnik J
Bioluminescence resonance energy transfer identify scaffold protein CNK1 interactions in intact cells.
FEBS letters 2005;579(3):648-54.
2004: McMurray John J V; Pfeffer Marc A; Swedberg Karl; Dzau Victor J
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
Circulation 2004;110(20):3281-8.
2004: Liew Choong-Chin; Dzau Victor J
Molecular genetics and genomics of heart failure.
Nature reviews. Genetics 2004;5(11):811-25.
2004: Morello Fulvio; de Bruin Tjerk W A; Rotter Jerome I; Pratt Richard E; van der Kallen Carla J H; Hladik Gary A; Dzau Victor J; Liew Choong-Chin; Chen Yii-Der I
Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(11):2149-54.
2004: Kong Deling; Melo Luis G; Gnecchi Massimiliano; Zhang Lunan; Mostoslavsky Gustavo; Liew Chong C; Pratt Richard E; Dzau Victor J
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries.
Circulation 2004;110(14):2039-46.
2004: Melo Luis G; Gnecchi Massimiliano; Pachori Alok S; Kong Deling; Wang Kai; Liu Xiaoli; Pratt Richard E; Dzau Victor J
Endothelium-targeted gene and cell-based therapies for cardiovascular disease.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(10):1761-74.
2004: Tamura Kouichi; Chen Yuqing E; Tanaka Yutaka; Sakai Masashi; Tsurumi Yuko; Koide Yuichi; Kihara Minoru; Pratt Richard E; Horiuchi Masatsugu; Umemura Satoshi; Dzau Victor J
Nuclear receptor LXRalpha is involved in cAMP-mediated human renin gene expression.
Molecular and cellular endocrinology 2004;224(1-2):11-20.
2004: Levy Bruce D; Katz Joel T; Wolf Marshall A; Sillman Jane S; Handin Robert I; Dzau Victor J
An initiative in mentoring to promote residents' and faculty members' careers.
Academic medicine : journal of the Association of American Medical Colleges 2004;79(9):845-50.
2004: Pachori Alok S; Melo Luis G; Hart Melanie L; Noiseux Nicholas; Zhang Lunan; Morello Fulvio; Solomon Scott D; Stahl Gregory L; Pratt Richard E; Dzau Victor J
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(33):12282-7.
2004: Gibbons Gary H; Liew Choong Chin; Goodarzi Mark O; Rotter Jerome I; Hsueh Willa A; Siragy Helmy M; Pratt Richard; Dzau Victor J
Genetic markers: progress and potential for cardiovascular disease.
Circulation 2004;109(25 Suppl 1):IV47-58.
2004: Stampfer Meir J; Ridker Paul M; Dzau Victor J
Risk factor criteria.
Circulation 2004;109(25 Suppl 1):IV3-5.
2004: Dzau Victor J
Markers of malign across the cardiovascular continuum: interpretation and application.
Circulation 2004;109(25 Suppl 1):IV1-2.
2004: Agrawal R S; Muangman S; Layne M D; Melo L; Perrella M A; Lee R T; Zhang L; Lopez-Ilasaca M; Dzau V J
Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival.
Gene therapy 2004;11(12):962-9.
2004: Melo Luis G; Pachori Alok S; Kong Deling; Gnecchi Massimiliano; Wang Kai; Pratt Richard E; Dzau Victor J
Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism.
Circulation 2004;109(20):2386-93.
2004: Tomita Naruya; Kim John Y S; Gibbons Gary H; Zhang Lunan; Kaneda Yasufumi; Stahl Rolf A K; Ogborn Malcom; Venderville Benoit; Morishita Ryuichi; Baran Dana; Dzau Victro J
Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
International journal of molecular medicine 2004;13(5):629-36.
2004: Braun-Dullaeus Ruediger C; Mann Michael J; Sedding Daniel G; Sherwood Steven W; von der Leyen Heiko E; Dzau Victor J
Cell cycle-dependent regulation of smooth muscle cell activation.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(5):845-50.
2004: Kong Deling; Melo Luis G; Mangi Abeel A; Zhang Lunan; Lopez-Ilasaca Marco; Perrella Mark A; Liew Chong C; Pratt Richard E; Dzau Victor J
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.
Circulation 2004;109(14):1769-75.
2004: Melo Luis G; Pachori Alok S; Kong Deling; Gnecchi Massimiliano; Wang Kai; Pratt Richard E; Dzau Victor J
Gene and cell-based therapies for heart disease.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(6):648-63.
2004: Pachori Alok S; Melo Luis G; Zhang Lunan; Loda Massimo; Pratt Richard E; Dzau Victor J
Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus.
Biochemical and biophysical research communications 2004;313(3):528-33.
2003: Lopez-Ilasaca Marco; Liu Xiushi; Tamura Koichi; Dzau Victor J
The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling.
Molecular biology of the cell 2003;14(12):5038-50.
2003: Dzau Victor J
Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010?
The American journal of cardiology 2003;92(9B):32N-35N.
2003: Dzau Victor J; Beatt Kevin; Pompilio Giulio; Smith Karen
Current perceptions of cardiovascular gene therapy.
The American journal of cardiology 2003;92(9B):18N-23N.
2003: Kleiman Neal S; Patel Nirav C; Allen Keith B; Simons Michael; Ylä-Herttuala Seppo; Griffin Elaine; Dzau Victor J
Evolving revascularization approaches for myocardial ischemia.
The American journal of cardiology 2003;92(9B):9N-17N.
2003: Griese Daniel P; Ehsan Afshin; Melo Luis G; Kong Deling; Zhang Lunan; Mann Michael J; Pratt Richard E; Mulligan Richard C; Dzau Victor J
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.
Circulation 2003;108(21):2710-5.
2003: Durier Séverine; Fassot Céline; Laurent Stéphane; Boutouyrie Pierre; Couetil Jean-Paul; Fine Erika; Lacolley Patrick; Dzau Victor J; Pratt Richard E
Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness.
Circulation 2003;108(15):1845-51.
2003: Mirotsou Maria; Watanabe Coran M H; Schultz Peter G; Pratt Richard E; Dzau Victor J
Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach.
Physiological genomics 2003;15(2):115-26.
2003: Mangi Abeel A; Noiseux Nicolas; Kong Deling; He Huamei; Rezvani Mojgan; Ingwall Joanne S; Dzau Victor J
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.
Nature medicine 2003;9(9):1195-201.
2003: Huber P E; Mann M J; Melo L G; Ehsan A; Kong D; Zhang L; Rezvani M; Peschke P; Jolesz F; Dzau V J; Hynynen K
Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery.
Gene therapy 2003;10(18):1600-7.
2003: Dzau Victor J; Glueck Susan B
The future of Physiological Genomics.
Physiological genomics 2003;14(3):167-8.
2003: Barrans J David; Ip James; Lam Ching-Wan; Hwang Irene L; Dzau Victor J; Liew Choong-Chin
Chromosomal distribution of the human cardiovascular transcriptome.
Genomics 2003;81(5):519-24.
2003: Anderson Leonard M; Choe Sung E; Yukhananov Rustam Y; Hopfner Rob L; Church George M; Pratt Richard E; Dzau Victor J
Identification of a novel set of genes regulated by a unique liver X receptor-alpha -mediated transcription mechanism.
The Journal of biological chemistry 2003;278(17):15252-60.
2003: Ranade Koustubh; Hinds David; Hsiung Chao Agnes; Chuang Lee-Ming; Chang Mau-Song; Chen Ying-Tsung; Pesich Robert; Hebert Joan; Chen Yii-Der I; Dzau Victor; Olshen Richard; Curb David; Botstein David; Cox David R; Risch Neil
A genome scan for hypertension susceptibility loci in populations of Chinese and Japanese origins.
American journal of hypertension 2003;16(2):158-62.
2003: Weinberg Ellen O; Mirotsou Maria; Gannon Joseph; Dzau Victor J; Lee Richard T; Pratt Richard E
Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload.
Physiological genomics 2003;12(2):113-27.
2002: Mann Michael J; Dzau Victor J
Molecular approaches for the treatment of atherosclerosis.
Cardiology clinics 2002;20(4):633-43.
2002: Morishita R; Gibbons G H; Kaneda Y; Zhang L; Ogihara T; Dzau V J
Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies.
The Journal of endocrinology 2002;175(2):475-85.
2002: Dzau Victor J; Braun-Dullaeus Ruediger C; Sedding Daniel G
Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.
Nature medicine 2002;8(11):1249-56.
2002: Tomita Naruya; Morishita Ryuichi; Yamamoto Kei; Higaki Jitsuo; Dzau Victor J; Ogihara Toshio; Kaneda Yasufumi
Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes.
The journal of gene medicine 2002;4(5):527-35.
2002: Ton Christopher; Stamatiou Dimitri; Dzau Victor J; Liew Choong-Chin
Construction of a zebrafish cDNA microarray: gene expression profiling of the zebrafish during development.
Biochemical and biophysical research communications 2002;296(5):1134-42.
2002: Wu Kwan-Dun; Hsiao Chin-Fu; Ho Low-Tone; Sheu Wayne Huey-Herng; Pei Dee; Chuang Lee-Ming; Curb David; Chen Yii-Der Ida; Tsai Hui-Ju; Dzau Victor J; Cox David; Tai Tong-Yuan
Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance sibling study.
Hypertension research : official journal of the Japanese Society of Hypertension 2002;25(4):529-36.
2002: Hwang Juey-Jen; Allen Paul D; Tseng George C; Lam Ching-Wan; Fananapazir Lameh; Dzau Victor J; Liew Choong-Chin
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.
Physiological genomics 2002;10(1):31-44.
2002: Aird William C; Glueck Susan B; Dzau Victor J; Pratt Richard E
Separating the wheat from the chaff: focus on "in silico data filtering to identify new angiogenesis targets from a large in vitro gene profile data set".
Physiological genomics 2002;10(1):1-3.
2002: Dzau Victor J
Transcription factor decoy.
Circulation research 2002;90(12):1234-6.
2002: Barrans J David; Allen Paul D; Stamatiou Dimitrios; Dzau Victor J; Liew Choong-Chin
Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.
The American journal of pathology 2002;160(6):2035-43.
2002: Ehsan Afshin; Mann Michael J; Dell'Acqua Giorgio; Tamura Koichi; Braun-Dullaeus Ruediger; Dzau Victor J
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.
Circulation 2002;105(14):1686-92.
2002: Dzau Victor J; Bernstein Kenneth; Celermajer David; Cohen Jerome; Dahlöf Björn; Deanfield John; Diez Javier; Drexler Helmut; Ferrari Roberto; Van Gilst Wiek; Hansson Lennart; Hornig Burkhard; Husain Ahsan; Johnston Colin; Lazar Harold; Lonn Eva; Lüscher Thomas; Mancini John; Mimran Albert; Pepine Carl; Rabelink Ton; Remme Willem; Ruilope Luis; Ruzicka Marcel; Schunkert Heribert; Swedberg Karl; Unger Thomas; Vaughan Douglas; Weber Michael
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(2):149-60.
2002: Glueck Susan B; Dzau Victor J
Physiological genomics: implications in hypertension research.
Hypertension 2002;39(2 Pt 2):310-5.
2002: Melo Luis G; Agrawal Reitu; Zhang Lunan; Rezvani Mojgan; Mangi Abeel A; Ehsan Afshin; Griese Daniel P; Dell'Acqua Giorgio; Mann Michael J; Oyama Junichi; Yet Shaw-Fang; Layne Matthew D; Perrella Mark A; Dzau Victor J
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.
Circulation 2002;105(5):602-7.
2001: Francis S C; Raizada M K; Mangi A A; Melo L G; Dzau V J; Vale P R; Isner J M; Losordo D W; Chao J; Katovich M J; Berecek K H
Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
Physiological genomics 2001;7(2):79-94.
2001: Dzau V J; Bernstein K; Celermajer D; Cohen J; Dahlöf B; Deanfield J; Diez J; Drexler H; Ferrari R; van Gilst W; Hansson L; Hornig B; Husain A; Johnston C; Lazar H; Lonn E; Lüscher T; Mancini J; Mimran A; Pepine C; Rabelink T; Remme W; Ruilope L; Ruzicka M; Schunkert H; Swedberg K; Unger T; Vaughan D; Weber M;
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
The American journal of cardiology 2001;88(9A):1L-20L.
2001: Ranade K; Wu K D; Risch N; Olivier M; Pei D; Hsiao C F; Chuang L M; Ho L T; Jorgenson E; Pesich R; Chen Y D; Dzau V; Lin A; Olshen R A; Curb D; Cox D R; Botstein D
Genetic variation in aldosterone synthase predicts plasma glucose levels.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(23):13219-24.
2001: Braun-Dullaeus R C; Mann M J; Seay U; Zhang L; von Der Leyen H E; Morris R E; Dzau V J
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(7):1152-8.
2001: Ranade K; Chang M S; Ting C T; Pei D; Hsiao C F; Olivier M; Pesich R; Hebert J; Chen Y D; Dzau V J; Curb D; Olshen R; Risch N; Cox D R; Botstein D
High-throughput genotyping with single nucleotide polymorphisms.
Genome research 2001;11(7):1262-8.
2001: Daviet L; Lehtonen J Y; Hayashida W; Dzau V J; Horiuchi M
Intracellular third loops in AT1 and AT2 receptors determine subtype specificity.
Life sciences 2001;69(5):509-16.
2001: Glueck S B; Dzau V J; Lee R; Pratt R E
Challenges of comparative expression profiling studies of complex diseases: mouse models of myocardial hypertrophy. Focus on "Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy".
Physiological genomics 2001;6(1):1-2.
2001: Dzau V J
Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.
Hypertension 2001;37(4):1047-52.
2001: Ehsan A; Mann M J; Dell'Acqua G; Dzau V J
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
The Journal of thoracic and cardiovascular surgery 2001;121(4):714-22.
2001: Dzau V J; Mann M J; Ehsan A; Griese D P
Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics.
The Journal of thoracic and cardiovascular surgery 2001;121(2):206-16.
2000: Mann M J; Dzau V J
Therapeutic applications of transcription factor decoy oligonucleotides.
The Journal of clinical investigation 2000;106(9):1071-5.
2000: Tamura K; Chen Y E; Lopez-Ilasaca M; Daviet L; Tamura N; Ishigami T; Akishita M; Takasaki I; Tokita Y; Pratt R E; Horiuchi M; Dzau V J; Umemura S
Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells.
The Journal of biological chemistry 2000;275(44):34619-27.
2000: Akishita M; Iwai M; Wu L; Zhang L; Ouchi Y; Dzau V J; Horiuchi M
Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice.
Circulation 2000;102(14):1684-9.
2000: Tamura K; Chen Y E; Chen Q; Nyui N; Horiuchi M; Takasaki I; Tamura N; Pratt R E; Dzau V J; Umemura S
Expression of renin-angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor.
Molecular and cellular biochemistry 2000;212(1-2):203-9.
2000: Tomita N; Morishita R; Tomita S; Gibbons G H; Zhang L; Horiuchi M; Kaneda Y; Higaki J; Ogihara T; Dzau V J
Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
Gene therapy 2000;7(15):1326-32.
2000: Tamura K; Chen Y E; Horiuchi M; Chen Q; Daviet L; Yang Z; Lopez-Ilasaca M; Mu H; Pratt R E; Dzau V J
LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8513-8.
2000: Morishita R; Gibbons G H; Kaneda Y; Ogihara T; Dzau V J
Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of gene therapy.
Biochemical and biophysical research communications 2000;273(2):666-74.
2000: Ranade K; Hsuing A C; Wu K D; Chang M S; Chen Y T; Hebert J; Chen Y I; Olshen R; Curb D; Dzau V; Botstein D; Cox D; Risch N
Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations.
American journal of hypertension 2000;13(6 Pt 1):704-9.
2000: Morishita R; Gibbons G H; Tomita N; Zhang L; Kaneda Y; Ogihara T; Dzau V J
Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(4):915-22.
2000: Holmes E W; Burks T F; Dzau V; Hindery M A; Jones R F; Kaye C I; Korn D; Limbird L E; Marchase R B; Perlmutter R; Sanfilippo F; Strom B L
Measuring contributions to the research mission of medical schools.
Academic medicine : journal of the Association of American Medical Colleges 2000;75(3):303-13.
2000: Akishita M; Horiuchi M; Yamada H; Zhang L; Shirakami G; Tamura K; Ouchi Y; Dzau V J
Inflammation influences vascular remodeling through AT2 receptor expression and signaling.
Physiological genomics 2000;2(1):13-20.
1999: Mann M J; Whittemore A D; Donaldson M C; Belkin M; Conte M S; Polak J F; Orav E J; Ehsan A; Dell'Acqua G; Dzau V J
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
Lancet 1999;354(9189):1493-8.
1999: von der Leyen H E; Braun-Dullaeus R; Mann M J; Zhang L; Niebauer J; Dzau V J
A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer.
Human gene therapy 1999;10(14):2355-64.
1999: Poston R S; Mann M J; Hoyt E G; Ennen M; Dzau V J; Robbins R C
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method.
Transplantation 1999;68(6):825-32.
1999: Braun-Dullaeus R C; Mann M J; Ziegler A; von der Leyen H E; Dzau V J
A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
The Journal of clinical investigation 1999;104(6):815-23.
1999: Akishita M; Yamada H; Dzau V J; Horiuchi M
Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor.
Biochemical and biophysical research communications 1999;261(2):345-9.
1999: Lehtonen J Y; Daviet L; Nahmias C; Horiuchi M; Dzau V J
Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis.
Molecular endocrinology (Baltimore, Md.) 1999;13(7):1051-60.
1999: Yamada H; Akishita M; Ito M; Tamura K; Daviet L; Lehtonen J Y; Dzau V J; Horiuchi M
AT2 receptor and vascular smooth muscle cell differentiation in vascular development.
Hypertension 1999;33(6):1414-9.
1999: Daviet L; Lehtonen J Y; Tamura K; Griese D P; Horiuchi M; Dzau V J
Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor.
The Journal of biological chemistry 1999;274(24):17058-62.
1999: Lehtonen J Y; Horiuchi M; Daviet L; Akishita M; Dzau V J
Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis.
The Journal of biological chemistry 1999;274(24):16901-6.
1999: Mann M J; Gibbons G H; Hutchinson H; Poston R S; Hoyt E G; Robbins R C; Dzau V J
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(11):6411-6.
1999: Horiuchi M; Hayashida W; Akishita M; Tamura K; Daviet L; Lehtonen J Y; Dzau V J
Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk.
Circulation research 1999;84(8):876-82.
1999: Brown M D; Halpert A; McKean S; Sussman A; Dzau V J
Assessing the value of hospitalists to academic health centers: Brigham and Women's Hospital and Harvard Medical School.
The American journal of medicine 1999;106(2):134-7.
1999: Pratt R E; Dzau V J
Genomics and hypertension: concepts, potentials, and opportunities.
Hypertension 1999;33(1 Pt 2):238-47.
1999: Horiuchi M; Yamada H; Akishita M; Ito M; Tamura K; Dzau V J
Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells.
Hypertension 1999;33(1):162-6.
1999: Akishita M; Ito M; Lehtonen J Y; Daviet L; Dzau V J; Horiuchi M
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.
The Journal of clinical investigation 1999;103(1):63-71.
1998: Horiuchi M; Akishita M; Dzau V J
Molecular and cellular mechanism of angiotensin II-mediated apoptosis.
Endocrine research 1998;24(3-4):307-14.
1998: Tomita N; Horiuchi M; Tomita S; Gibbons G H; Kim J Y; Baran D; Dzau V J
An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
The American journal of physiology 1998;275(2 Pt 2):F278-84.
1998: Dzau V J; Horiuchi M
Vascular remodeling--the emerging paradigm of programmed cell death (apoptosis): the Francis B. Parker lectureship.
Chest 1998;114(1 Suppl):91S-99S.
1998: Braun-Dullaeus R C; Mann M J; Dzau V J
Cell cycle progression: new therapeutic target for vascular proliferative disease.
Circulation 1998;98(1):82-9.
1998: Poston R S; Tran K P; Mann M J; Hoyt E G; Dzau V J; Robbins R C
Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(4):349-55.
1998: Morishita R; Gibbons G H; Horiuchi M; Kaneda Y; Ogihara T; Dzau V J
Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.
Biochemical and biophysical research communications 1998;243(2):361-7.
1998: Dzau V J; von der Leyen H E; Morishita R
The concept and potentials of cardiovascular gene therapy.
Indian heart journal 1998;50(1):23-33.
1998: Yamada T; Akishita M; Pollman M J; Gibbons G H; Dzau V J; Horiuchi M
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study.
Life sciences 1998;63(19):PL289-95.
1997: Dzau V J; Gibbons G H; Mann M; Braun-Dullaeus R
Future horizons in cardiovascular molecular therapeutics.
The American journal of cardiology 1997;80(9A):33I-39I.
1997: Hein L; Meinel L; Pratt R E; Dzau V J; Kobilka B K
Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand.
Molecular endocrinology (Baltimore, Md.) 1997;11(9):1266-77.
1997: Mann M J; Morishita R; Gibbons G H; von der Leyen H E; Dzau V J
DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.
Molecular and cellular biochemistry 1997;172(1-2):3-12.
1997: Horiuchi M; Hayashida W; Kambe T; Yamada T; Dzau V J
Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis.
The Journal of biological chemistry 1997;272(30):19022-6.
1997: Hein L; Stevens M E; Barsh G S; Pratt R E; Kobilka B K; Dzau V J
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6391-6.
1997: Kaneda Y; Morishita R; Dzau V J
Prevention of restenosis by gene therapy.
Annals of the New York Academy of Sciences 1997;811():299-308; discussion 308-10.
1997: Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau V J; Kaneda Y; Higaki J; Ogihara T
Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
Journal of molecular and cellular cardiology 1997;29(3):949-59.
1997: Katsuya T; Horiuchi M; Minami S; Koike G; Santoro N F; Hsueh A J; Dzau V J
Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome.
Molecular and cellular endocrinology 1997;127(2):221-8.
1997: Mann M J; Gibbons G H; Tsao P S; von der Leyen H E; Cooke J P; Buitrago R; Kernoff R; Dzau V J
Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts.
The Journal of clinical investigation 1997;99(6):1295-301.
1996: Dzau V J; Horiuchi M
In vivo gene transfer and gene modulation in hypertension research.
Hypertension 1996;28(6):1132-7.
1996: Diet F; Pratt R E; Berry G J; Momose N; Gibbons G H; Dzau V J
Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.
Circulation 1996;94(11):2756-67.
1996: Dzau V J; Mann M J; Morishita R; Kaneda Y
Fusigenic viral liposome for gene therapy in cardiovascular diseases.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11421-5.
1996: von der Leyen H E; Mann M J; Dzau V J
Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders.
Seminars in interventional cardiology : SIIC 1996;1(3):209-14.
1996: Hayashida W; Horiuchi M; Dzau V J
Intracellular third loop domain of angiotensin II type-2 receptor. Role in mediating signal transduction and cellular function.
The Journal of biological chemistry 1996;271(36):21985-92.
1996: Ellison K E; Bishopric N H; Webster K A; Morishita R; Gibbons G H; Kaneda Y; Sato B; Dzau V J
Fusigenic liposome-mediated DNA transfer into cardiac myocytes.
Journal of molecular and cellular cardiology 1996;28(7):1385-99.
1996: Yamada T; Horiuchi M; Dzau V J
Angiotensin II type 2 receptor mediates programmed cell death.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):156-60.
1995: Hein L; Dzau V J; Barsh G S
Linkage mapping of the angiotensin AT2 receptor gene (Agtr2) to the mouse X chromosome.
Genomics 1995;30(2):369-71.
1995: Nakajima M; Hutchinson H G; Fujinaga M; Hayashida W; Morishita R; Zhang L; Horiuchi M; Pratt R E; Dzau V J
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(23):10663-7.
1995: Koike G; Jacob H J; Krieger J E; Szpirer C; Hoehe M R; Horiuchi M; Dzau V J
Investigation of the phenylethanolamine N-methyltransferase gene as a candidate gene for hypertension.
Hypertension 1995;26(4):595-601.
1995: von der Leyen H E; Dzau V J
[Experimental approaches for gene therapy modification of vascular remodeling]
Zeitschrift für Kardiologie 1995;84(10):791-7.
1995: Hein L; Barsh G S; Pratt R E; Dzau V J; Kobilka B K
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice.
Nature 1995;377(6551):744-7.
1995: Yamada T; Horiuchi M; Morishita R; Zhang L; Pratt R E; Dzau V J
In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.
The Journal of clinical investigation 1995;96(3):1230-7.
1995: Horiuchi M; Koike G; Yamada T; Mukoyama M; Nakajima M; Dzau V J
The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and -2.
The Journal of biological chemistry 1995;270(34):20225-30.
1995: Mukoyama M; Horiuchi M; Nakajima M; Pratt R E; Dzau V J
Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells.
Molecular and cellular endocrinology 1995;112(1):61-8.
1995: Katsuya T; Koike G; Yee T W; Sharpe N; Jackson R; Norton R; Horiuchi M; Pratt R E; Dzau V J; MacMahon S
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease.
Lancet 1995;345(8965):1600-3.
1995: Katsuya T; Horiuchi M; Chen Y D; Koike G; Pratt R E; Dzau V J; Reaven G M
Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(6):779-82.
1995: Morishita R; Gibbons G H; Horiuchi M; Ellison K E; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau V J
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(13):5855-9.
1995: Mann M J; Gibbons G H; Kernoff R S; Diet F P; Tsao P S; Cooke J P; Kaneda Y; Dzau V J
Genetic engineering of vein grafts resistant to atherosclerosis.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(10):4502-6.
1995: Ohno M; Cooke J P; Dzau V J; Gibbons G H
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade.
The Journal of clinical investigation 1995;95(3):1363-9.
1995: Gregory C R; Huang X; Pratt R E; Dzau V J; Shorthouse R; Billingham M E; Morris R E
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.
Transplantation 1995;59(5):655-61.
1995: von der Leyen H E; Gibbons G H; Morishita R; Lewis N P; Zhang L; Nakajima M; Kaneda Y; Cooke J P; Dzau V J
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(4):1137-41.
1995: Dzau V J; Gibbons G H; Kobilka B K; Lawn R M; Pratt R E
Genetic models of human vascular disease.
Circulation 1995;91(2):521-31.
1994: Dzau V J
Pathobiology of atherosclerosis and plaque complications.
American heart journal 1994;128(6 Pt 2):1300-4.
1994: Morishita R; Gibbons G H; Kaneda Y; Ogihara T; Dzau V J
Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.
Gene 1994;149(1):13-9.
1994: Morishita R; Gibbons G H; Ellison K E; Lee W; Zhang L; Yu H; Kaneda Y; Ogihara T; Dzau V J
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.
The Journal of clinical investigation 1994;94(3):978-84.
1994: Koike G; Horiuchi M; Yamada T; Szpirer C; Jacob H J; Dzau V J
Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung.
Biochemical and biophysical research communications 1994;203(3):1842-50.
1994: Morishita R; Gibbons G H; Pratt R E; Tomita N; Kaneda Y; Ogihara T; Dzau V J
Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth.
The Journal of clinical investigation 1994;94(2):824-9.
1994: Dzau V J
Cell biology and genetics of angiotensin in cardiovascular disease.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(4):S3-10.
1994: Dzau V J; Mukoyama M; Pratt R E
Molecular biology of angiotensin receptors: target for drug research?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(2):S1-5.
1994: Rakugi H; Wang D S; Dzau V J; Pratt R E
Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation.
Circulation 1994;90(1):449-55.
1994: Dzau V J; Gibbons G H; Morishita R; Pratt R E
New perspectives in hypertension research. Potentials of vascular biology.
Hypertension 1994;23(6 Pt 2):1132-40.
1994: Morishita R; Gibbons G H; Ellison K E; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau V J
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
The Journal of clinical investigation 1994;93(4):1458-64.
1994: Koike G; Krieger J E; Jacob H J; Mukoyama M; Pratt R E; Dzau V J
Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme.
Biochemical and biophysical research communications 1994;198(1):380-6.
1994: Kim D K; Zhang L; Dzau V J; Pratt R E
H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury.
The Journal of clinical investigation 1994;93(1):355-60.
1994: Rakugi H; Kim D K; Krieger J E; Wang D S; Dzau V J; Pratt R E
Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.
The Journal of clinical investigation 1994;93(1):339-46.
1993: Nakajima M; Mukoyama M; Pratt R E; Horiuchi M; Dzau V J
Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor.
Biochemical and biophysical research communications 1993;197(2):393-9.
1993: Mukoyama M; Nakajima M; Horiuchi M; Sasamura H; Pratt R E; Dzau V J
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.
The Journal of biological chemistry 1993;268(33):24539-42.
1993: Malek A M; Gibbons G H; Dzau V J; Izumo S
Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium.
The Journal of clinical investigation 1993;92(4):2013-21.
1993: Horiuchi M; Pratt R E; Nakamura N; Dzau V J
Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression.
The Journal of clinical investigation 1993;92(4):1805-11.
1993: Morishita R; Gibbons G H; Ellison K E; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau V J
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8474-8.
1993: Ohno M; Gibbons G H; Dzau V J; Cooke J P
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling.
Circulation 1993;88(1):193-7.
1993: Morishita R; Gibbons G H; Kaneda Y; Ogihara T; Dzau V J
Novel and effective gene transfer technique for study of vascular renin angiotensin system.
The Journal of clinical investigation 1993;91(6):2580-5.
1993: Morishita R; Gibbons G H; Kaneda Y; Ogihara T; Dzau V J
Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells.
Hypertension 1993;21(6 Pt 2):894-9.
1993: Itoh H; Mukoyama M; Pratt R E; Gibbons G H; Dzau V J
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.
The Journal of clinical investigation 1993;91(5):2268-74.
1993: Schunkert H; Tang S S; Litwin S E; Diamant D; Riegger G; Dzau V J; Ingelfinger J R
Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat.
Cardiovascular research 1993;27(5):731-5.
1993: Dzau V J; Sasamura H; Hein L
Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(3):S13-8.
1993: Omoigui N; Dzau V J
Differential effects of antihypertensive agents in experimental and human atherosclerosis.
American journal of hypertension 1993;6(3 Pt 2):30S-39S.
1993: Dzau V J; Gibbons G H; Cooke J P; Omoigui N
Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives.
Circulation 1993;87(3):705-19.
1993: Schunkert H; Ingelfinger J R; Hirsch A T; Pinto Y; Remme W J; Jacob H; Dzau V J
Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II.
Circulation research 1993;72(2):312-8.
1993: Gregory C R; Pratt R E; Huie P; Shorthouse R; Dzau V J; Billingham M E; Morris R E
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Transplantation proceedings 1993;25(1 Pt 1):770-1.
1993: Dzau V J
The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.
Current opinion in nephrology and hypertension 1993;2(1):27-32.
1993: Morishita R; Gibbons G H; Ellison K E; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau V J
Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
Transactions of the Association of American Physicians 1993;106():54-61.
1993: Dzau V J; Gibbons G H
Vascular remodeling: mechanisms and implications.
Journal of cardiovascular pharmacology 1993;21 Suppl 1():S1-5.
1993: Dzau V J
Vascular renin-angiotensin system and vascular protection.
Journal of cardiovascular pharmacology 1993;22 Suppl 5():S1-9.
1992: Itoh H; Mukoyama M; Pratt R E; Dzau V J
Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide.
Biochemical and biophysical research communications 1992;188(3):1205-13.
1992: Schunkert H; Ingelfinger J R; Jacob H; Jackson B; Bouyounes B; Dzau V J
Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
The American journal of physiology 1992;263(5 Pt 1):E863-9.
1992: Hirsch A T; Talsness C E; Smith A D; Schunkert H; Ingelfinger J R; Dzau V J
Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Circulation 1992;86(5):1566-74.
1992: Schunkert H; Ingelfinger J R; Hirsch A T; Tang S S; Litwin S E; Talsness C E; Dzau V J
Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.
The Journal of clinical investigation 1992;90(4):1523-9.
1992: Creager M A; Gallagher S J; Girerd X J; Coleman S M; Dzau V J; Cooke J P
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.
The Journal of clinical investigation 1992;90(4):1248-53.
1992: Dzau V J
Autocrine and paracrine mechanisms in the pathophysiology of heart failure.
The American journal of cardiology 1992;70(10):4C-11C.
1992: Gibbons G H; Pratt R E; Dzau V J
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
The Journal of clinical investigation 1992;90(2):456-61.
1992: Tang S S; Rogg H; Schumacher R; Dzau V J
Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors.
Endocrinology 1992;131(1):374-80.
1992: Itoh H; Pratt R E; Ohno M; Dzau V J
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.
Hypertension 1992;19(6 Pt 2):758-61.
1992: Dzau V J
Angiotensin converting enzyme inhibitors and the cardiovascular system.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(3):S3-10.
1992: Andrawis N S; Dzau V J; Pratt R E
Autocrine stimulation of mas oncogene leads to altered growth control.
Cell biology international reports 1992;16(6):547-56.
1992: Sasamura H; Hein L; Krieger J E; Pratt R E; Kobilka B K; Dzau V J
Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome.
Biochemical and biophysical research communications 1992;185(1):253-9.
1992: Paul M; Burt D W; Krieger J E; Nakamura N; Dzau V J
Tissue specificity of renin promoter activity and regulation in mice.
The American journal of physiology 1992;262(5 Pt 1):E644-50.
1992: Zuo W M; Pratt R E; Heusser C H; Bews J P; de Gasparo M M; Dzau V J
Characterization of a monoclonal antibody specific for human active renin.
Hypertension 1992;19(3):249-54.
1992: Barrett G; Horiuchi M; Paul M; Pratt R E; Nakamura N; Dzau V J
Identification of a negative regulatory element involved in tissue-specific expression of mouse renin genes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(3):885-9.
1992: Paul M; Nakamura N; Pratt R E; Burt D W; Dzau V J
Cell-dependent posttranslational processing and secretion of recombinant mouse renin-2.
The American journal of physiology 1992;262(2 Pt 1):E224-9.
1992: Hirsch A T; Dzau V J; Cutler S S; Levenson D J; Creager M A
Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients.
Journal of cardiovascular pharmacology 1992;19(2):272-81.
1991: Andrawis N S; Brock T A; Dzau V J; Pratt R E
Mas oncogene receptor coupling and peptide specificity in Balb 3T3 and vascular smooth muscle cells.
The American journal of the medical sciences 1991;302(6):329-34.
1991: Dzau V J; Gibbons G H
Endothelium and growth factors in vascular remodeling of hypertension.
Hypertension 1991;18(5 Suppl):III115-21.
1991: Cooke J P; Rossitch E; Andon N A; Loscalzo J; Dzau V J
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.
The Journal of clinical investigation 1991;88(5):1663-71.
1991: Dzau V J; Gibbons G H; Pratt R E
Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
Hypertension 1991;18(4 Suppl):II100-5.
1991: Krieger J E; Dzau V J
Molecular biology of hypertension.
Hypertension 1991;18(3 Suppl):I3-17.
1991: Horiuchi M; Nakamura N; Tang S S; Barrett G; Dzau V J
Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP. Identification of an inhibitory protein that binds nuclear transcriptional factor.
The Journal of biological chemistry 1991;266(24):16247-54.
1991: Hirsch A T; Talsness C E; Schunkert H; Paul M; Dzau V J
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.
Circulation research 1991;69(2):475-82.
1991: Jacob H J; Sigmund C D; Shockley T R; Gross K W; Dzau V J
Renin promoter SV40 T-antigen transgenic mouse. A model of primary renal vascular hyperplasia.
Hypertension 1991;17(6 Pt 2):1167-62.
1991: Dubin D; Pratt R E; Hui K Y; Dzau V J
Characterization of prorenin activation using a synthetic peptide substrate.
Journal of hypertension 1991;9(6):483-6.
1991: Itoh H; Pratt R E; Dzau V J
Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth.
Biochemical and biophysical research communications 1991;176(3):1601-9.
1991: Naftilan A J; Zuo W M; Inglefinger J; Ryan T J; Pratt R E; Dzau V J
Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall.
The Journal of clinical investigation 1991;87(4):1300-11.
1991: Dzau V; Braunwald E
Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement.
American heart journal 1991;121(4 Pt 1):1244-63.
1991: Dzau V J; Gibbons G
Does hypertension potentiate atherosclerosis via vascular hypertrophy?
Journal of cardiovascular pharmacology 1991;17 Suppl 2():S34.
1990: Girerd X J; Hirsch A T; Cooke J P; Dzau V J; Creager M A
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.
Circulation research 1990;67(6):1301-8.
1990: Schunkert H; Dzau V J; Tang S S; Hirsch A T; Apstein C S; Lorell B H
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.
The Journal of clinical investigation 1990;86(6):1913-20.
1990: Takeuchi K; Nakamura N; Cook N S; Pratt R E; Dzau V J
Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway.
Biochemical and biophysical research communications 1990;172(3):1189-94.
1990: Itoh H; Pratt R E; Dzau V J
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
The Journal of clinical investigation 1990;86(5):1690-7.
1990: Hirsch A T; Pinto Y M; Schunkert H; Dzau V J
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure.
The American journal of cardiology 1990;66(11):22D-30D; discussion 30D-32D.
1990: Ingelfinger J R; Schunkert H; Ellison K E; Pivor M; Zuo W M; Pratt R; Dzau V J
Intrarenal angiotensinogen: localization and regulation.
Pediatric nephrology (Berlin, Germany) 1990;4(4):424-8.
1990: Creager M A; Cooke J P; Mendelsohn M E; Gallagher S J; Coleman S M; Loscalzo J; Dzau V J
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.
The Journal of clinical investigation 1990;86(1):228-34.
1990: Creager M A; Hirsch A T; Dzau V J; Nabel E G; Cutler S S; Colucci W S
Baroreflex regulation of regional blood flow in congestive heart failure.
The American journal of physiology 1990;258(5 Pt 2):H1409-14.
1990: Ingelfinger J R; Zuo W M; Fon E A; Ellison K E; Dzau V J
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system.
The Journal of clinical investigation 1990;85(2):417-23.
1990: Tang S S; Stevenson L; Dzau V J
Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion.
Circulation research 1990;66(1):103-8.
1990: Dzau V J
Atherosclerosis and hypertension: mechanisms and interrelationships.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S59-64.
1989: Naftilan A J; Williams R; Burt D; Paul M; Pratt R E; Hobart P; Chirgwin J; Dzau V J
A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension.
Hypertension 1989;14(6):614-8.
1989: Rudd M A; Plavin S; Hirsch A T; Ingelfinger J R; Dzau V J
Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation.
Circulation research 1989;65(5):1324-9.
1989: Dzau V J; Ingelfinger J R
Molecular biology and pathophysiology of the intrarenal renin-angiotensin system.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(7):S3-8.
1989: Hirsch A T; Dzau V J; Majzoub J A; Creager M A
Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.
The Journal of clinical investigation 1989;84(2):418-26.
1989: Hirsch A T; Levenson D J; Cutler S S; Dzau V J; Creager M A
Regional vascular responses to prolonged lower body negative pressure in normal subjects.
The American journal of physiology 1989;257(1 Pt 2):H219-25.
1989: Naftilan A J; Pratt R E; Eldridge C S; Lin H L; Dzau V J
Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.
Hypertension 1989;13(6 Pt 2):706-11.
1989: Ellison K E; Ingelfinger J R; Pivor M; Dzau V J
Androgen regulation of rat renal angiotensinogen messenger RNA expression.
The Journal of clinical investigation 1989;83(6):1941-5.
1989: Dzau V J; Paul M; Nakamura N; Pratt R E; Ingelfinger J R
Role of molecular biology in hypertension research. State of the Art lecture.
Hypertension 1989;13(6 Pt 2):731-40.
1989: Burt D W; Nakamura N; Kelley P; Dzau V J
Identification of negative and positive regulatory elements in the human renin gene.
The Journal of biological chemistry 1989;264(13):7357-62.
1989: Dubin D; Hui K; Pratt R E; Dzau V J
Synthetic peptide inhibitors of prorenin activation.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(2):S71-3.
1989: Ingelfinger J R; Pratt R E; Roth T P; Dzau V J
Processing of one-chain to two-chain renin in the mouse submandibular gland is influenced by androgen.
Pediatric research 1989;25(4):332-5.
1989: Naftilan A J; Pratt R E; Dzau V J
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.
The Journal of clinical investigation 1989;83(4):1419-24.
1989: Pratt R E; Zou W M; Naftilan A J; Ingelfinger J R; Dzau V J
Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat.
The American journal of physiology 1989;256(3 Pt 2):F469-74.
1989: Dzau V J; Creager M A
Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses.
Cardiology clinics 1989;7(1):119-30.
1989: Dzau V J
Treatment strategies: an evaluation of antihypertensive therapy.
The American journal of medicine 1989;86(1B):113-5.
1989: Sacks F M; Creager M A; Gallagher S J; Loscalzo J; Dzau V J
Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
The American journal of medicine 1989;86(1B):8-13.
1989: Nakamura N; Burt D W; Paul M; Dzau V J
Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(1):56-9.
1989: Hirsch A T; Creager M A; Dzau V J
Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure.
The American journal of cardiology 1989;63(3):211-6.
1989: Dzau V J
Short- and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin systems.
Journal of cardiovascular pharmacology 1989;14 Suppl 4():S1-5.
1989: Dzau V J
Factors influencing the lipid response to selective alpha 1-inhibition.
Journal of cardiovascular pharmacology 1989;13 Suppl 2():S50-2; discussion S52.
1988: Dzau V J
Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: the effects of antihypertensive agents.
American heart journal 1988;116(6 Pt 2):1725-8.
1988: Paul M; Nakamura N; Pratt R E; Dzau V J
Glycosylation influences intracellular transit time and secretion rate of human prorenin in transfected cells.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S487-9.
1988: Burt D W; Nakamura N; Kelley P; Dzau V J
Functional human renin promoter in transfected cells: evidence for cell-specific expression.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S429-31.
1988: Dzau V J
Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(3):S7-12.
1988: Dzau V J
Evolving concepts of the renin-angiotensin system. Focus on renal and vascular mechanisms.
American journal of hypertension 1988;1(4 Pt 2):334S-337S.
1988: Dzau V J; Burt D W; Pratt R E
Molecular biology of the renin-angiotensin system.
The American journal of physiology 1988;255(4 Pt 2):F563-73.
1988: Dzau V J; Gibbons G H
Cell biology of vascular hypertrophy in systemic hypertension.
The American journal of cardiology 1988;62(11):30G-35G.
1988: Pratt R E; Carleton J E; Roth T P; Dzau V J
Evidence for two cellular pathways of renin secretion by the mouse submandibular gland.
Endocrinology 1988;123(4):1721-7.
1988: Dzau V J
Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.
The American journal of cardiology 1988;62(8):76E-81E.
1988: Dzau V J
Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction.
Circulation 1988;77(6 Pt 2):I1-3.
1988: Dzau V J
Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
Circulation 1988;77(6 Pt 2):I4-13.
1988: Creager M A; Hirsch A T; Nabel E G; Cutler S S; Colucci W S; Dzau V J
Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure.
Journal of the American College of Cardiology 1988;11(6):1191-8.
1988: Dzau V J; Safar M E
Large conduit arteries in hypertension: role of the vascular renin-angiotensin system.
Circulation 1988;77(5):947-54.
1988: Dzau V J
Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors.
The American journal of medicine 1988;84(4A):4-8.
1988: Ingelfinger J R; Pratt R E; Dzau V J
Regulation of extra-renal renin during ontogeny.
Endocrinology 1988;122(3):782-6.
1988: Dzau V J
Cardiac renin-angiotensin system. Molecular and functional aspects.
The American journal of medicine 1988;84(3A):22-7.
1988: Pratt R E; Flynn J A; Hobart P M; Paul M; Dzau V J
Different secretory pathways of renin from mouse cells transfected with the human renin gene.
The Journal of biological chemistry 1988;263(7):3137-41.
1988: Paganelli W C; Cant J R; Pintal R R; Kifor I; Barger A C; Dzau V J
Plasma atrial natriuretic factor during chronic thoracic inferior vena caval constriction.
Circulation research 1988;62(2):279-85.
1988: Paul M; Burt D W; Nakamura N; Pratt R E; Dzau V J
Mapping of the human renin transcription start site: evidence for a single functional promoter.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(6):1313-6.
1988: Tang S S; Dzau V J
Partial purification of a prorenin activating enzyme in the aortic wall.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(6):1251-7.
1988: Pratt R E; Burt D W; Nakamura N; Paul M; Dzau V J
Identification of potential regulatory regions in the renin gene.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(6):1141-6.
1987: Dzau V J; Gibbons G H
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.
The American journal of cardiology 1987;60(17):99I-103I.
1987: Pratt R E; Carleton J E; Richie J P; Heusser C; Dzau V J
Human renin biosynthesis and secretion in normal and ischemic kidneys.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(22):7837-40.
1987: Dzau V J; Swartz S L
Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
The American journal of cardiology 1987;60(13):1101-5.
1987: Farhi E R; Cant J R; Paganelli W C; Dzau V J; Barger A C
Stimulus-response curve of the renal baroreceptor: effect of converting enzyme inhibition and changes in salt intake.
Circulation research 1987;61(5):670-7.
1987: Dzau V J; Baxter J A; Cantin M; de Bold A; Ganten D; Gross K; Husain A; Inagami T; Menard J; Poole S
Report of the Joint Nomenclature and Standardization Committee of the International Society of Hypertension, American Heart Association and the World Health Organization.
Journal of hypertension 1987;5(4):507-11.
1987: Dzau V J; Rosenthal J; Swales J D
Vascular renin--a consensus view.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1987;5(2):S77-8.
1987: Dzau V J
Possible prorenin activating mechanisms in the blood vessel wall.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1987;5(2):S15-8.
1987: Dzau V J; Ellison K E; Brody T; Ingelfinger J; Pratt R E
A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues.
Endocrinology 1987;120(6):2334-8.
1987: Dzau V J; Brody T; Ellison K E; Pratt R E; Ingelfinger J R
Tissue-specific regulation of renin expression in the mouse.
Hypertension 1987;9(6 Pt 2):III36-41.
1987: Dzau V J
Vascular angiotensin pathways: a new therapeutic target.
Journal of cardiovascular pharmacology 1987;10 Suppl 7():S9-16.
1987: Dzau V J; Sacks F M
Regulation of lipoprotein metabolism by adrenergic mechanisms.
Journal of cardiovascular pharmacology 1987;10 Suppl 9():S2-6.
1987: Dzau V J
Molecular studies of human renin structure and synthesis using monoclonal antibodies.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(8-9):1291-304.
1986: Ingelfinger J R; Pratt R E; Ellison K; Dzau V J
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla.
The Journal of clinical investigation 1986;78(5):1311-5.
1986: Dzau V J; Ingelfinger J; Pratt R E; Ellison K E
Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains.
Hypertension 1986;8(6):544-8.
1986: Ingelfinger J R; Pratt R E; Ellison K E; Roth T P; Dzau V J
Multiple sites of regulation of mouse renin expression in ontogeny.
Clinical and experimental hypertension. Part A, Theory and practice 1986;8(4-5):687-94.
1984: Gibbons G H; Dzau V J; Farhi E R; Barger A C
Interaction of signals influencing renin release.
Annual review of physiology 1984;46():291-308.
1983: Mizoguchi H; Dzau V J; Siwek L G; Barger A C
Effect of intrarenal administration of dopamine on renin release in conscious dogs.
The American journal of physiology 1983;244(1):H39-45.
1981: Dzau V J; Siwek L G; Rosen S; Farhi E R; Mizoguchi H; Barger A C
Sequential renal hemodynamics in experimental benign and malignant hypertension.
Hypertension 1981;3(3 Pt 2):I63-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Victor Dzau

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Procedures

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Victor Dzau (preview)

All Publications